Leishmania donovani pteridine reductase 1: Biochemical properties and structure-modeling studies.

Pranav Kumar, Ashutosh Kumar, Shyam Sundar Verma, Namrata Dwivedi, Nasib Singh, Mohammad Imran Siddiqi, Rama Pati Tripathi, Anuradha Dube, Neeloo Singh

Drug Target Discovery and Development, Central Drug Research Institute, Chattat Manzil, P.O. Box No. 173, Lucknow 226001, India.

Journal Article: Experimental Parasitology (impact factor: 1.6). 07/2008; DOI: 10.1016/j.exppara.2008.05.005

Abstract

Pteridine reductase 1 (PTR1, EC 1.5.1.33) is a NADPH dependent short-chain reductase (SDR) responsible for the salvage of pterins in the protozoan parasite Leishmania. This enzyme acts as a metabolic bypass for drugs targeting dihydrofolate reductase, therefore, for successful antifolate chemotherapy to be developed against Leishmania, it must target both enzyme activities. Based on homology model drawn on recombinant pteridine reductase isolated from a clinical isolate of L. donovani, we carried out molecular modeling and docking studies with two compounds of dihydrofolate reductase specificity showing promising antileishmanial activity in vitro. Both the inhibitors appeared to fit well in the active pocket revealing the tight binding of the carboxylic acid ethyl ester group of pyridine moiety to pteridine reductase and identify the important interactions necessary to assist the structure based development of novel pteridine reductase inhibitors.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Science & Research Jobs

Keywords

active pocket revealing
 
carboxylic acid ethyl ester group
 
dihydrofolate reductase
 
dihydrofolate reductase specificity
 
docking studies
 
enzyme activities
 
enzyme acts
 
homology model
 
molecular modeling
 
NADPH dependent short-chain reductase
 
novel pteridine reductase inhibitors
 
promising antileishmanial activity
 
protozoan parasite Leishmania
 
pteridine reductase
 
Pteridine reductase 1
 
PTR1
 
recombinant pteridine reductase
 
salvage
 
successful antifolate chemotherapy